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ABSTRACT: Prolyl oligopeptidase B from Galerina marginata (GmPOPB) has recently been discovered as a peptidase capable
of breaking and forming peptide bonds to yield a cyclic peptide. Despite the relevance of prolyl oligopeptidases in human biology
and disease, a kinetic analysis pinpointing rate-limiting steps for a member of this enzyme family is not available. Macrocyclase
enzymes are currently exploited to produce cyclic peptides with potential therapeutic applications. Cyclic peptides are promising
druglike molecules because of their stability and conformational rigidity. Here we describe an in-depth kinetic characterization of
a prolyl oligopeptidase acting as a macrocyclase enzyme. By combining steady-state and pre-steady-state kinetics, we propose a
kinetic sequence in which a step after macrocyclization limits steady-state turnover. Additionally, product release is ordered,
where the cyclic peptide departs ﬁrst followed by the peptide tail. Dissociation of the peptide tail is slow and signiﬁcantly
contributes to the turnover rate. Furthermore, trapping of the enzyme by the peptide tail becomes signiﬁcant beyond initial rate
conditions. The presence of a burst of product formation and a large viscosity eﬀect further support the rate-limiting nature of a
physical step occurring after macrocyclization. This is the ﬁrst detailed description of the kinetic sequence of a macrocyclase
enzyme from this class. GmPOPB is among the fastest macrocyclases described to date, and this work is a necessary step toward
designing broad-speciﬁcity eﬃcient macrocyclases.
The prolyl oligopeptidase (POP) family comprises endo-and exopeptidases that can be identiﬁed in all domains of
life.1 Their importance lies in the fact that very few general
proteases can cleave at a proline residue because of the unique
conformational properties they attribute to peptides. As the
majority of peptide hormones and neuropeptides contain
proline residues, biology has evolved speciﬁc proline
oligopeptidases2 to process and degrade such substrates.
Recently, an enzyme belonging to the prolyl oligopeptidase
family but capable of catalyzing both cleavage and formation of
a peptide bond (in a macrocyclization reaction) was identiﬁed.3
Prolyl oligopeptidase B from Galerina marginata (GmPOPB)
participates in the biosynthesis of amanitins, a family of
mushroom toxins. Amanitins are characterized by an eight-
amino acid peptide core sequence, IWGIGC(N/D)P, a
distinctive sulfoxide tryptathionine cross-link between trypto-
phan and cysteine, and varying degrees of hydroxylation
(Scheme S1).4 Around 90% of all poison-related fatalities
caused by mushrooms are due to cyclic peptide toxins of the
amanitin family.5
Amanitins are ribosomally synthesized and post-translation-
ally modiﬁed peptides (RiPPs),6 comprising a class of
molecules that are attractive as sources of new medicines.
RiPPs are characterized by their synthesis, catalyzed by
individual enzymes working in cascade, acting on a genetically
encoded peptide precursor, which contains a core peptide
(comprising the ﬁnal cyclic product) ﬂanked by disposable
recognition “tags”.6 The products are often highly modiﬁed by
oxidation, hydroxylation, and prenylation.7 Macrocyclic RiPPs
are particularly promising as druglike molecules as they are
structurally rigid and inherently resistant to protease degrada-
tion and penetrate the cell.8 Four classes of peptide
macrocyclases involved in RiPP biosynthesis have been
identiﬁed to date.3,9−12 The most well characterized are
PatGmac13 (and homologues), from the patellamide pathway,
and the asparaginyl endopeptidase Butelase 1, from the plant
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Clitoria ternatea.10 PatGmac has been shown to be a highly
versatile tool in the production of cyclic peptides.14−16
However, PatGmac reactions are very slow in vitro,11 although
addition of reductant to Escherichia coli cultures improves
production of the cyclic peptide patellin using the homologous
tru enzymes by multiple orders of magnitude.17 Butelase 1 is
remarkably fast and eﬀective as a tool for producing large
peptide macrocycles,18−20 but it cannot eﬀectively cyclize
peptide substrates containing nine or fewer amino acids.21 The
initial characterization of the macrocyclization reaction of the
GmPOPB enzyme has shown it possesses a catalytic rate much
faster than that of PatGmac in vitro (albeit slower than Butelase
1), and that its natural substrate yields a macrocycle that
contains eight amino acids.3
The substrate used by GmPOPB to form a cyclic peptide as a
ﬁnal product is ribosomally encoded as a 35-amino acid
peptide. GmPOPB ﬁrst catalyzes peptide bond hydrolysis in
this precursor peptide, cleaving oﬀ 10 N-terminal residues
(leader peptide). The resulting peptide with 25 amino acids
(25mer) is then utilized by GmPOPB as a substrate for the
macrocyclization reaction (Scheme S1). During the macro-
cyclase reaction, GmPOPB generates an eight-amino acid cyclic
peptide from the N-terminal residues (the core), cleaving oﬀ
the 17-C-terminal amino acid recognition sequence (peptide
tail). This tail is thought to be required for peptide recognition
by GmPOPB, and truncations were shown to cause loss of
macrocyclase activity.3 Scheme 1 summarizes the macro-
cyclization reaction.
Here we have established the kinetic sequence for the
macrocyclase activity of GmPOPB. We combined steady-state
and pre-steady-state kinetics to dissect rate-limiting steps in the
reaction. This work is the ﬁrst step toward elucidating
GmPOPB’s mechanism and should contribute to the engineer-
ing of more eﬃcient macrocyclases.
■ EXPERIMENTAL PROCEDURES
Materials. The 25mer peptide was purchased from
Biosynthesis, as free amine and free carboxylic acid, at a purity
of >90% and used without further puriﬁcation. Buﬀers and
chemicals, unless speciﬁed, were from Sigma. The peptide tail
and cyclic peptide were produced enzymatically by performing
a 5 mL reaction with 5 μM GmPOPB and 500 μM 25mer as
the starting material. The unreacted peptide, cyclic product, and
17-amino acid peptide tail were separated by high-performance
liquid chromatography (HPLC) (Agilent inﬁnity 1260 series,
Agilent Technologies) using a Macherey-Nagel Nucleodur C18
column (10 μm × 16 mm × 250 mm) and a gradient from a
0.1% TFA aqueous solution to 32−40% acetonitrile (10 mL/
min). Fractions containing each peptide of interest were
pooled; their identity and purity were veriﬁed by LC−MS, and
the fractions were lyophilized for subsequent use. Figure S9
shows the HPLC trace for the puriﬁcation of the cyclic peptide
and recognition tail, as well as high-resolution mass
spectrometry for the puriﬁed compounds. Concentrations of
peptides were calculated on the basis of their absorbance at 280
nm (ε280‑25mer = 11000 M
−1 cm−1, ε280‑cyclic = 5500 M
−1 cm−1,
and ε280‑tail = 5500 M
−1 cm−1).22
Expression and Puriﬁcation of Recombinant Proteins.
Plasmid pJExpress414 encoding the codon-optimized G.
marginata POPB gene was purchased from DNA 2.0. Plasmids
were transformed into BL21(DE3) cells (Agilent). Cultures
(100 mL) were grown overnight at 37 °C in the presence of
100 μg/mL ampicillin and then diluted 100-fold into 6 L of
Terriﬁc Broth (TB) medium. These cultures were grown at 37
°C while being shaken (200 rpm) until the optical density at
600 nm (OD600) reached 0.6. Cells were cooled for 1 h to 16
°C, and protein expression was then induced by the addition of
0.5 mM isopropyl β-D-thiogalactopyranoside (IPTG, Generon).
Cultures were incubated for an additional 16 h and centrifuged
at 6000g for 15 min. Cell pellets were resuspended in 250 mL
of nickel lysis/wash buﬀer [50 mM HEPES (pH 8.0), 300 mM
NaCl, 10 mM imidazole, 10% glycerol, and 2 mM β-
mercaptoethanol] supplemented with cOmplete EDTA-free
protease inhibitor tablets (Roche Applied Science). The
resulting suspension was lysed by two passages through a cell
homogenizer at 30K psi and puriﬁed by nickel chromatography
using a HisTrap FF column (GE Healthcare). Each desired
protein was eluted using a step elution with lysis buﬀer
supplemented with 250 mM imidazole (buﬀer B). Eluted
protein was dialyzed overnight against buﬀer C [50 mM
HEPES (pH 8.0), 50 mM NaCl, 10% glycerol, and 2 mM β-
mercaptoethanol], while simultaneously, the His tag was being
cleaved by TEV protease.23 This dialyzed TEV-cleaved mixture
was loaded onto a HisTrap column connected in tandem to a
HiTrap Q FF column (GE Healthcare). Both columns were
washed with buﬀer C, and GmPOPB was eluted during this
wash. Fractions were pooled and concentrated to <8 mL (at 10
mg/mL approximately). Protein was loaded onto a Superdex
S200 gel ﬁltration column (GE Healthcare) pre-equilibrated
with storage buﬀer D [50 mM HEPES (pH 8.0), 50 mM NaCl,
10% glycerol, and 2 mM β-mercaptoethanol]. Fractions
containing pure protein were combined, concentrated, divided
into aliquots, ﬂash-frozen, and stored at −80 °C. Protein
concentrations were determined by the absorbance at 280
nm.22 Protein purity was assessed by sodium dodecyl sulfate−
polyacrylamide gel electrophoresis (>95%).
Scheme 1. Macrocyclization Reaction Catalyzed by GmPOPBa
aThe core sequence is colored green, the core proline pink, and the peptide tail blue.
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Site-Directed Mutagenesis. To generate the inactive
mutant S577A, the mutagenesis protocol described by Liu and
Naismith was employed.24 Oligonucleotides for mutagenesis
were purchased from IDT, and their sequence is shown in
Table S2. To verify that no other alterations in the sequence
were introduced, sequencing was performed using at least three
primers to cover the entire gene sequence (Euroﬁns).
General Procedure for Kinetic Assays under Steady-
State Conditions. The standard buﬀer for routine assays
consisted of 50 mM Tris (pH 8.0), 50 mM NaCl, and 10 mM
DTT. Reactions were started by adding GmPOPB. Unless
stated otherwise, all experiments were performed in duplicate.
The reaction was quenched at several time points by adding 50
μL of the reaction mixture to 20 μL of 6% TFA. Figure S8
shows that the reaction is quenched by this procedure.
Reactants were separated from products for quantiﬁcation by
injecting 60 μL of each quenched time point onto a ZORBAX
SB-C18, 5 μm, 9.4 mm × 50 mm (Agilent) column connected
to an Agilent LC−MS instrument (G6130B Single Quad,
Agilent Technologies). Reactants were separated from products
using a gradient from A (H2O with 0.1% TFA or H2O with
0.1% formic acid) to 50% B (acetonitrile), at a rate of 1.5 mL/
min for 8 min. The area of each peak (reactant and cyclic
peptide product) was integrated, and the percentage of product
formed was calculated by correcting the absorbance values for
diﬀerences in the extinction coeﬃcient of each peptide
(ε280‑25mer = 11000 M
−1 cm−1, ε220‑25mer = 46000 M
−1 cm−1,
ε280‑cyclic = 5500 M
−1 cm−1, ε220‑cyclic = 34000 M
−1 cm−1, and
ε280‑tail = 5500 M
−1 cm−1). After this, the sum of product plus
substrate was considered equal to the total initial amount of
substrate present, and the concentration of product formed was
calculated in molar. The amount of product formed in molar
over time was plotted to yield the micromolar cyclic product
formed per second. The slope of this line was corrected for the
concentration of enzyme present to yield v/Et (s
−1), replotted
as a function of peptide concentration and ﬁtted to eq 1 to
obtain Michaelis−Menten parameters.
pH−Rate Proﬁles and Temperature Studies. Before
measuring the temperature dependence and pH dependence of
kcat and kcat/Km, we incubated the enzyme for 10 min at the
desired pH or temperature, after which it was diluted in the
standard reaction mixture and assayed under standard
conditions [50 mM Tris (pH 8.0), 50 mM NaCl, 10 mM
DTT, and 100 μM 25mer peptide substrate] to ensure that the
protein was not unfolded and remained active upon being
incubated under the tested conditions. For pH−rate proﬁles,
reactions were performed at 37 °C with the 25mer substrate.
Reactions were started by adding GmPOPB (concentrations
ranging from 5 to 50 nM), and the following buﬀers were used,
all at 100 mM: Bis-Tris (pH 6.5 and 6.8), Tris (pH 6.7, 7.1, 7.5,
7.7, 8.2, and 8.8 at 37 °C), CHES (pH 9.0 and 10.0), and CAPS
(pH 10.0 and 10.5). Buﬀers with overlapping pH values were
used when switching between buﬀers.25 Data from the kcat/
Km−pH proﬁle were ﬁtted to eq 2. Temperature studies were
performed in 100 mM HEPES (pH 8.0) with 50 mM NaCl and
10 mM DTT, at 5 °C increments from 10 to 45 °C. Data for
the Arrhenius plot for kcat and kcat/Km were ﬁtted to eq 4.
SKIEs and Viscosity. Solvent kinetic isotope eﬀects
(SKIEs) were measured with the 25mer peptide in either
H2O or 98% D2O at 37 °C. Reactions were started by adding
GmPOPB (20, 60, or 60 nM for reactions in H2O, D2O, or 9%
glycerol, respectively), and initial velocities in the presence of
varying concentrations of the peptide substrate were obtained.
Eﬀects caused by viscosity were evaluated by comparing the
rates obtained in H2O, and 9% glycerol, to mimic the relative
viscosity of D2O (ηr = 1.24).
26 To eliminate eﬀects caused by
small variations in pH, measurements were performed at a
plateau region observed in the pH−rate proﬁles (pL 8.0). pL
values were measured using a pH meter, and buﬀers prepared
in D2O had their pD value calculated with the relationship pD
= pH* + 0.4, where pH* is the reading obtained on the pH
meter.27 Curves for H2O, D2O, and 9% glycerol were
performed simultaneously in duplicate, and each set of
experiments was repeated three times. All data from separate
experiments were averaged and analyzed to give the values
reported here.
Pre-Steady-State Experiments Using a Quenched-
Flow Apparatus. Single and multiple turnovers were
monitored using a QFM-4000 (Biologic) quenched-ﬂow
apparatus (laboratory of D. Lilley at the University of Dundee,
Dundee, U.K.). All experiments were performed at 20 °C, in
duplicate. Equal volumes of GmPOPB and 25mer substrate
were mixed, and the reaction was quenched with 6% TFA at
various times and analyzed by LC−MS as described above. For
single-turnover experiments, 44, 75, and 100 μM GmPOPB
were mixed with 10 μM 25mer substrate and data were ﬁtted to
a single-exponential equation (eq 5). For multiple-turnover
experiments, 10 μM GmPOPB was mixed with 100 or 200 μM
25mer substrate and data were ﬁtted to a single-exponential
equation followed by a linear phase (eq 6). All concentrations
are ﬁnal, after mixing. Final ﬁtted numbers reported in Table 2
were obtained by global ﬁtting using numerical integration in
Kintek Global Explorer28 followed by Fitspace29 error analysis,
as described below. Analytical ﬁts were used to obtain only
initial estimates for kinetic parameters. All ﬁtted values reported
in Table 2 and Figure 5 were obtained by global ﬁtting using
numerical integration.
Pre-Steady-State Fluorescence Experiments. Binding
and dissociation rate constants were measured by stopped-ﬂow
ﬂuorescence quenching or enhancement on a SX-20 stopped-
ﬂow apparatus (Applied Photophysics), by exciting tryptophan
residues at 285 nm and monitoring ﬂuorescence emission
above 320 nm. All experiments were performed at 20 °C.
Traces shown are the average of 6−10 kinetic traces. A
minimum of 1000 time points were collected per trace. Control
experiments without enzyme were conducted to evaluate the
presence of inner ﬁlter eﬀects, which were insigniﬁcant in the
range of peptide concentrations employed here. Traces
obtained by mixing peptide and buﬀer were subtracted from
traces obtained by mixing protein and peptide.
Analytical ﬁtting was performed only when peptide
concentrations exceeded 5 times the concentration of enzyme
to maintain pseudo-ﬁrst-order conditions. Analytical ﬁts for the
25mer substrate and peptide tail are shown in Figures S2−S5.
Final ﬁtted numbers listed in Table 2 were obtained by global
ﬁtting using numerical integration in Kintek Global Explorer28
followed by Fitspace29 error analysis, as described below.
Analytical ﬁts were used to obtain only initial estimates for
kinetic parameters. All ﬁtted values reported in Table 2 and
Figure 5 were obtained by global ﬁtting using numerical
integration. All data points were included when data were
analyzed numerically (described below). For 25mer binding
experiments, the GmPOPB-S577A concentration was 1 μM,
and the 25mer peptide concentration was varied from 0.2 to 25
μM. For binding of the peptide tail, the GmPOPB
concentration was 2 μM, and the peptide concentration was
Biochemistry Article
DOI: 10.1021/acs.biochem.7b00012
Biochemistry XXXX, XXX, XXX−XXX
C
varied from 0.5 to 20 μM. For cyclic peptide binding, the
GmPOPB-S577A concentration was 2 μM, the peptide tail
(WTAEHVDQTLASGNDIC) concentration was 5.3 μM (in
the same syringe as GmPOPB-S577A), and the cyclic peptide
concentration was varied from 0.5 to 2 μM. Concentrations of
>2 μM showed poor signal amplitude because most of the
signal was lost in the instrument’s dead time. All concentrations
are ﬁnal (after mixing).
Isothermal Titration Calorimetry (ITC). Titrations were
performed on a MicroCal PEAQ-ITC instrument (MicroCal,
Malvern Instruments, Northamption, MA), and the results
were ﬁtted using the PEAQ-ITC analysis software (MicroCal,
Malvern Instruments). Stock solutions of 25- and 17mers were
prepared in 20 mM Tris (pH 8.0) containing 1 mM DTT. Both
were buﬀer-exchanged by three cycles of dilution in 50 mM
Tris (pH 8.0) with 50 mM NaCl and 10 mM DTT followed by
concentration using a Microsep Advance centrifugal device with
a 1 kDa cutoﬀ membrane (Pall Corp.). The native and S577A
proteins were treated in the same manner but concentrated
using a Vivaspin protein concentrator spin column (30 kDa
cutoﬀ, GE Healthcare). A ﬁnal dilution to the concentration to
be used for titration was performed using the buﬀer that passed
through during the protein buﬀer exchange, both for the
protein and peptide to match buﬀers. The stirred cell contained
300 μL of 20 μM protein, and the injection syringe contained
75 μL of 200 μM 25mer or peptide tail ligands. Titrations of
peptide into protein solutions were conducted at 20 °C. A total
of 19 injections of 2 μL were made at 120 s intervals; the ﬁrst
injection was discarded from analysis. Blank runs in which
peptides were titrated into buﬀer were performed to correct for
the heats of dilution and mixing, and the dilution isotherm for
each peptide ligand was subtracted from the respective binding
isotherm prior to curve ﬁtting. Equilibrium dissociation
constants (Kd) as well as ΔH and ΔS values for binding of
each peptide to the protein were obtained by ﬁtting the
calorimetric data with a single-site model using stoichiometry
parameter n ﬁxed at 1.0. Fits in which stoichiometry parameter
n was allowed to vary were performed, resulting in an n
approaching 1 and no diﬀerence in Kd values within
experimental error when n was varied or ﬁxed at 1.0.
Equations Used for Analytical Data Fitting. Kinetic data
were ﬁtted to a Michaelis−Menten equation (eq 1)
= ×
+
v
V E S
K S
( / )t
m (1)
where v is initial velocity, V/Et is the maximal velocity corrected
for enzyme concentration, Km is the Michaelis−Menten
constant, and S is the concentration of the peptide substrate.
pH−rate proﬁle data were ﬁtted to eq 2, describing the
presence of a bell-shaped pH curve with one ionizable group in
the acidic limb and one in the basic limb.
=
+ +− − − −
⎛
⎝⎜
⎞
⎠⎟y
C
log
1 10 /10 10 /10K KpH p p pHa1 a2 (2)
where y is the kinetic parameter, C is the pH-independent value
of y, pH is the experimental pH, and pKa1 and pKa2 are
apparent acid dissociation constants for ionizing groups.
Deuterium solvent isotope eﬀects and viscosity eﬀects were
calculated by dividing the values obtained for kinetic
parameters in H2O by those obtained in D2O. The ratio is
the observed eﬀect. This value has no units because it results
from a division of H2Okcat/
D2Okcat and (
H2Okcat/Km)/(
D2Okcat/Km).
Errors were propagated using eq 3.
δ δ δ δ δ= + + +Q Q a a b b c c d d( / ) ( / ) ( / ) ( / )2 2 2 2 (3)
where δQ is the error on parameter Q (to be determined), δa is
the error on parameter a, δb is the error on parameter b, etc.
Temperature eﬀects were ﬁtted to an Arrhenius equation (eq
4)
= +k E R T Alog ( /2.3 )(1/ ) loga (4)
where k is kcat or kcat/Km at a given temperature, Ea is the energy
of activation, T is the temperature in kelvin, R is the gas
constant (1.98 cal mol−1), and A is a pre-exponential factor that
correlates collision frequency and the probability of the reaction
occurring when reactant molecules collide.
Data for single-turnover and multiple-turnover experiments
were ﬁtted to eqs 5 and 6, respectively
= +−y t A C( ) e kt (5)
= + +−y t A vt C( ) e kt (6)
where y(t) is the amount of cyclic peptide formed (micro-
molar) at time t, A is the amplitude of the transient, k is the
observed rate constant for the transient, C is the oﬀset, and v is
the slope of the linear phase observed in multiple-turnover
experiments.
The apparent dissociation constant for a two-step binding
process (Kov) is deﬁned by eq 7
=
+
−
−
K
k k
k k k( )ov
1 2
1 2 2 (7)
where k1 and k2 are association rate constants for the ﬁrst and
second phases, respectively, and k−1 and k−2 are dissociation
rate constants for the ﬁrst and second phases, respectively.
Equation 7 was adapted from ref 30.
To obtain the free energy proﬁle shown in Figure 5, eq 8 was
used with a temperature of 20 °C (293.15 K)
Δ =†
⎛
⎝⎜
⎞
⎠⎟G RT
k T h
k
ln
/
i
i
B
(8)
where ΔGi† is the energy barrier for any given step, R is the gas
constant (1.98 cal mol−1), T is the temperature in kelvin, κB and
h are Boltzmann’s and Planck’s constants, respectively, and ki is
the rate constant for any given step.
All data ﬁtted analytically are represented as means ± the
standard error.
Data Fitting by Numerical Integration. Global ﬁtting
combining quenched-ﬂow and stopped-ﬂow data from all
experiments to the mechanism proposed here (single turnover
and multiple turnover, binding of 25mer, binding of peptide
tail, and binding of the cyclic peptide to the GmPOPB−tail
complex, shown in Figure 5) and global ﬁtting of individual
experiments with concentration series (Table S1) were
performed by regression analysis based upon numerical
integration of the rate equations using KinTek Global Kinetic
Explorer version 6.0 (KinTek Corp., Austin, TX).31 For
diﬀerent ligand concentrations, scaling factors were included
in the data ﬁtting process, and estimates for errors on
parameters were derived by nonlinear regression and by
Fitspace conﬁdence contour analysis.28,29,31
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Initially, each experiment was globally ﬁtted in isolation to
obtain estimates for kinetic rate constants and scaling factors, as
well as to test for alternative models. During this phase, no
constraints were imposed on ﬁtting and all parameters were
allowed to vary freely. Data obtained for each individual ﬁt are
listed in Table S1. Once a model was considered constrained
and a good ﬁt to the data from each separate experiment was
performed, the parameters obtained were used as the starting
point for the simultaneous global ﬁtting of ﬁve experiments
(single turnover, multiple turnover, binding of 25mer substrate,
binding of peptide tail, and binding of cyclic peptide to
GmPOPB-tail) to the model depicted in Figure 5. For global
ﬁtting of all experiments, k1 and k−1 and k5 and k−5 were linked
according to Kd values from ITC experiments [Kd‑25mer‑S577A =
44 ± 10 nM, and Kd‑tail = 442 ± 60 nM (Figure S11)].
Chemistry was considered irreversible (k−2 = 0). Additionally,
k4 and k−4 were ﬁxed at their best-ﬁt values. After global ﬁtting,
results were analyzed by Fitspace contour analysis. A χ2
threshold limit of 0.833 was used for the boundary search,
and results are reported as the χ2 threshold at the boundary for
each parameter (χ2 = 0.996). Gray lines on Figures 2 and 3
represent Fitspace boundaries for the rate constants listed in
Table 2.
■ RESULTS
Kinetic Characterization of GmPOPB. An LC−MS
spectrum of a typical time course reaction for the
recombinantly produced enzyme operating under initial rate
conditions is shown in Figure 1A. The following kinetic
parameters were obtained in H2O: Km‑25mer = 51 μM, and
kcat‑25mer = 35 min
−1 (or 0.58 s−1) (at 37 °C); Km‑25mer = 55 μM,
and kcat‑25mer = 14 min
−1 (or 0.23 s−1) (at 20 °C).
pH−Rate Proﬁle and Temperature Eﬀects. GmPOPB
remains active over the broad pH rage studied here (6.5−10.5).
Because of very high Km values at extreme pH values, it could
not be assayed robustly outside this range; however, incubation
for several minutes at pH 5 and 11 showed that activity was
recovered upon a return to pH 8.0. No pH dependence was
observed on kcat, while a bell-shaped proﬁle with two ionizable
groups (one general acid and one general base) was observed
for kcat/Km (Figure 1B). pKa values of 7.6 ± 0.5 and 8.7 ± 0.4
were obtained. Temperature studies were performed from 10 to
45 °C, and a linear dependence of kcat on temperature was
observed, indicating that the rate-determining step is constant
within this temperature range (Figure 1C). Data ﬁtting to an
Arrhenius equation yielded an activation energy of 8.5 kcal
mol−1 for kcat. This value is similar to the activation energy for
proteolysis for the POP from Pyrococcus furiosus32 but
signiﬁcantly smaller than the value reported for Sus scrofa
(porcine) POP, which varied from 14 to 20 kcal mol−1
depending on the substrate used.33 The activation energy
calculated for kcat/Km is 11.1 kcal mol
−1. The activation energy
for kcat/Km represents the highest energy barrier from the
association of the free enzyme and free substrate, up to and
including the ﬁrst irreversible step in this reaction, usually
considered to be the formation of the acyl−enzyme
intermediate for a protease-type reaction.34
Solvent and Viscosity Eﬀects. Given the kcat/Km proﬁle
exhibited a pronounced bell-shaped pH−rate proﬁle (Figure
1B), solvent kinetic isotope eﬀects were measured to probe the
rate-limiting nature of protonation steps (Figure 1D). The
following values were obtained: D2Okcat = 6.0 ± 0.8, and
D2Okcat/
Km = 3.5 ± 1.3 [which could suggest rate-limiting protonation
step(s)]. Because D2O has a relative viscosity higher than that
of H2O and has been shown to aﬀect solvent isotope eﬀect
experiments35 as well as to aﬀect the rate of reaction when
conformational changes are rate-limiting,36 a control experi-
ment using glycerol at a concentration matching the relative
viscosity of deuterated water was performed. The following
viscosity eﬀects were observed: 9%Glykcat = 7.3 ± 1.0, and
9%Glykcat/Km = 2.1 ± 0.9 (which are similar within experimental
error to the values obtained in the isotope eﬀect experiment).
Pre-Steady-State Kinetics. Single-Turnover and Burst
Kinetics. We performed single- and multiple-turnover experi-
Figure 1. Steady-state characterization of GmPOPB. (A) Representative LC−MS trace for the reaction quenched at diﬀerent time points showing a
decrease for the substrate (25mer) and an increase for the cyclic peptide over time. (B) pH−rate proﬁles for GmPOPB. The kcat proﬁle is colored
blue, and the kcat/Km proﬁle is colored purple. (C) Temperature studies. The kcat proﬁle is colored blue, and the kcat/Km proﬁle is colored purple. (D)
Solvent kinetic isotope eﬀects (H2O in purple circles, D2O in blue squares) and viscosity with 9% glycerol (pink circles). For all data, error bars are
standard errors of the mean.
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ments to estimate the rate of chemistry. It is important to point
out that the rate of chemistry reported here (k2) is not a
microscopic rate constant but instead a macroscopic constant
encompassing the rates of formation of the ﬁrst tetrahedral
intermediate, the acyl−enzyme intermediate, formation of a
second tetrahedral intermediate leading to formation of the
cyclic peptide, and any possible conformational changes that
might be associated with these events. In the single-turnover
experiments using 44 μM enzyme substrate, binding still
contributed to the observed rate because the observed rate
constant was smaller than those observed at 75 and 100 μM
GmPOPB. Increasing the concentration of enzyme, we
observed the same rate constant within experimental error
when 75 and 100 μM GmPOPB were employed (Figure 2A).
With 75 μM GmPOPB, by analytical ﬁtting, a transient with a
kchem‑obs of 1.07 s
−1 was observed, with an amplitude of 8.77
μM. Because the concentration of substrate used was 10 μM,
this demonstrates that the enzyme utilized is close to 90%
active. The fact that the macroscopic rate of chemistry is faster
than kcat implies the system should exhibit burst kinetics, and
indeed, we observed such behavior (Figure 2B). The value
obtained for kburst was 1.26 s
−1 (as expected, higher than
kchem‑obs), while the kcat obtained for the linear phase was 0.13 ±
0.07 s−1, in good agreement with the kcat obtained under initial
rate conditions (Table 1). Quenched-ﬂow data ﬁtted globally
(single and multiple turnovers) are shown in Figure 2, where
Fitspace boundaries at χ2 = 0.996 are shown as gray lines.
Stopped-Flow Experiments for Binding and Product
Release Steps. Stopped-ﬂow data ﬁtted globally are shown in
Figure 3 (25mer binding, tail binding, and cyclic peptide
binding to the GmPOPB−tail complex), and Fitspace
boundaries at χ2 = 0.996 are shown as gray lines. Binding of
the 25mer substrate (Figure 3A) and the tail sequence (Figure
3B) displayed single transients. Analytical ﬁtting showed a
linear dependence of kobs on peptide concentration (Figures S2
and S4). This is diagnostic of a single-step binding event.
Additionally, Fitspace29 analysis testing both one-step and two-
step binding mechanisms conﬁrmed that 25mer and tail
binding occurred each in a single step, as two-step binding
mechanisms could not be ﬁt to the data. Binding of the cyclic
peptide product to the GmPOPB−tail complex was a two-step
process, with a very fast transient followed by a slower phase
(Figure 3C,D). Binding experiments using cyclic peptide and
GmPOPB showed no observable change in the ﬂuorescence
signal (Figure S6). Because both the protein and the cyclic
peptide contain tryptophan residues, a signal for binding
(which was observed in all other binding experiments
performed) was expected unless such interaction is very weak
or nonexistent (Figure S6). After global ﬁtting, the kinetic
parameters obtained are listed in Table 2. Initial ﬁtting was well
constrained for all kinetic parameters except for k4 and k−4, a
fast bimolecular step with very small amplitude for which most
of the ﬁrst transient was lost in the dead time of the stopped-
ﬂow instrument. Fitspace analysis when k4 and k−4 were free to
vary revealed a very wide conﬁdence interval, and these
parameters were not well constrained by the data (Table S1).
Therefore, k4 and k−4 were ﬁxed at their best-ﬁt values during
global ﬁtting. Figure 4 shows the results of the Fitspace error
analysis, in which each pair of rate constants is well-constrained,
possessing a well-deﬁned local minimum. The best-ﬁt values for
each rate constant reveal that macromolecular rate k2 is
comparable in magnitude to that of tail release (k5), indicating
that both contribute to the turnover rate.
■ DISCUSSION
GmPOPB is an unusual peptidase, catalyzing the canonical
reaction of its enzyme class, i.e., peptide bond cleavage
Figure 2. Global ﬁtting of data from single-turnover and multiple-
turnover experiments under pre-steady-state conditions. Fitspace
boundaries at χ2 = 0.996 are shown as gray lines. (A) Single-turnover
experiment with 75 μM GmPOPB and 10 μM 25mer substrate (purple
circles). (B) Multiple-turnover experiment with 100 μM (purple
circles) and 200 μM (pink circles) 25mer substrate and 10 μM
GmPOPB. The reaction was quenched with a quenched-ﬂow
apparatus, and the concentration of the cyclic peptide product was
determined using the LC−MS-based assay described in Experimental
Procedures. For all data, error bars are standard errors of the mean.
Table 1. Kinetic Parameters, Equilibrium Constants, and
Kinetic Constantsa
parameter or rate constant value obtained by analytical ﬁtting
Kd‑25mer
b (nM) 44 ± 10
Kd‑tail
b (nM) 442 ± 60
Kd‑tail
c (nM) 731
Kov‑cyclic
d (nM) 99.2
Km‑25mer (μM) 55.4 ± 18.6
kcat‑25mer, experimental (s
−1) 0.23 ± 0.03
kcat‑25mer,
e calculated (s−1) 0.25
kchem‑obs (s
−1) 1.07 ± 0.08
STO amplitude (μM) 8.77 ± 0.18
kburst (s
−1) 1.26 ± 0.56
MTO (burst) amplitude (μM) 8.4 ± 2.7
kcat‑burst (s
−1) 0.13 ± 0.07
aAll values were obtained at 20 °C, with 50 mM Tris-HCl (pH 8.0),
50 mM NaCl, and 10 mM DTT. For data ﬁtted analytically, error
values are standard errors of the mean using experimental values in
duplicate, and not errors for the tolerance of the ﬁt. bMeasured by ITC
(Figure S11). cCalculated by Kd‑tail = k−5/k5.
dCalculated according to
eq 7. eCalculated according to eq S1.
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following a proline, but also peptide bond formation to
generate a cyclic peptide. Here we have for the ﬁrst time
determined the kinetic sequence for the macrocyclase reaction
performed by a prolyl oligopeptidase enzyme. Despite
substantial kinetic information being available for proteases of
other classes, POPs remain less well explored. This is the ﬁrst
pre-steady-state study of both a POP and a macrocyclase
enzyme.37
Previously, GmPOPB was produced in G. marginata
mushrooms after transformation with Agrobacterium tumefa-
ciens.3 Here, the enzyme was produced recombinantly in E. coli,
and the kinetic parameters are comparable to those of the
enzyme puriﬁed from mushroom, although kcat is 9-fold
smaller.3 The most eﬃcient macrocyclase characterized to
date is Butelase 1 (kcat/Km = 10700 M
−1 s−1 when using a
modiﬁed sequence for cyclotide kalata B1).10 GmPOPB has a
kcat/Km of 3255 M
−1 s−1, being the most eﬃcient macrocyclase
when using short substrates (eight amino acids in the core
sequence).
Our results show that GmPOPB employs acid−base catalysis
with pKa values separated by only ∼1 pH unit. In comparison,
when a dipeptide was used as a substrate for porcine POP,
three ionizable groups with pKa values of 5, 7, and 9.5 were
observed.38−40 In the porcine enzyme, titration of the catalytic
histidine (His680, equivalent to His698 in GmPOPB) revealed
a pKa of 6.25 for this group, slightly smaller than those observed
for other serine proteases (∼7).41,42 The pKa value of 9.5 was
attributed to instability of the protein at high pH,43 while the
two lower pKa values were credited to two interconverting
enzyme forms in solution at acidic pH.1 POP from P. furiosus
showed pKa values for kcat/Km of 4.7, 7.7, and 8.7.
32 However,
this enzyme displayed a high solvent kinetic isotope eﬀect and
was thought to possess a mechanism akin to that of
chymotrypsin, in which proton transfer is the rate-limiting
step.32
Because the putative catalytic triad of GmPOPB includes
histidine 698, it is possible that both pKa values observed here
reﬂect ionization states for this residue. According to the
mechanism proposed in Scheme S2, histidine 698 has a neutral
charge when substrate binds but is protonated when tetrahedral
Figure 3. Stopped-ﬂow binding. Global ﬁtting of experiments under pre-steady-state conditions. Experiments were performed by monitoring
tryptophan ﬂuorescence (ﬂuorescence excitation at 285 nm and emission above 320 nm). Fitspace boundaries at χ2 = 0.996 are shown as gray lines.
(A) Binding of the tail sequence to GmPOPB. (B) Binding of the 25mer substrate to GmPOPB. (C) Binding of the cyclic peptide to the GmPOPB−
tail complex. Data are shown as the change in ﬂuorescence upon binding; i.e., traces were subtracted from data obtained with only the GmPOPB−
tail complex. (D) Close-up of the red box in panel C showing two transients upon cyclic peptide binding.
Table 2. Rate Constants and Boundaries Obtained by
Numerical Fitting of All Experiments to the Model Depicted
in Figure 5a
parameter or
rate constant
Kintek best-ﬁt
value
boundaries obtained by numerical ﬁtting
(χ2 = 0.996 at boundary)
k1
b (μM−1 s−1) 7.82 ± 0.05 7.5−8.11
k−1
b (s−1) 0.313 ± 0.02
k2 (s
−1) 0.86 ± 0.01 0.774−0.932
k3 (s
−1) 12.33 ± 1.69 5.05−27.7
k−3 (μM
−1 s−1) 0.78 ± 0.08 0.435−0.952
k4
c (s−1) 100 23.9−435
k−4
c (μM−1 s−1) 60 58−286
k5
b (s−1) 1.44 ± 0.01 1.42−1.47
k−5
b (μM−1 s−1) 3.22 ± 0.01
aErrors for Kintek best-ﬁt values are standard deviations. bRate
constants that were linked during global ﬁtting based on ITC Kd values
(Figure S11). cRate constants kept constant at their best-ﬁt values
during global ﬁtting.
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intermediates are formed. This is in agreement with the bell-
shaped kcat/Km pH−rate proﬁle observed for GmPOPB. The
values are in the vicinity observed for apparent pKa values for
histidine residues in enzymatic hydrophobic pockets.44,45
Importantly, GmPOPB is a macrocyclase capable of utilizing
the longest peptide substrate described for a POP,37 and the
two pKa values observed are close, suggesting that ionizable
groups occupy a diﬀerent environment in comparison to that of
porcine POP, which solely hydrolyzes peptide bonds. Explain-
ing pKa shifts in enzyme active sites is not trivial because there
can be a contribution from electrostatics, hydrogen bonding,
and other processes.45−47 Mutagenesis studies are being
performed to determine the role of histidine 698 and other
conserved residues in the vicinity of the active site of GmPOPB.
Our steady-state results pointed toward a step other than a
bond forming or breaking event as being rate-limiting. The
absence of pH dependence on kcat, a large viscosity eﬀect, and a
very small or nonexistent solvent kinetic isotope eﬀect are
indicative of a rate-limiting binding event. Analysis under pre-
steady-state conditions revealed a burst of product formation
and a slow dissociation rate constant for one of the products of
the reaction (the peptide tail). A simulation performed with
Kintek Global Explorer in which the value for the dissociation
rate constant for the tail (k5) was varied revealed the eﬀect this
rate constant has on steady-state turnover (Figure S7). If the
ﬁtted value for k5 (1.44 s
−1) was decreased to 0.5 s−1, while all
other kinetic parameters remained unchanged (except for k−5
to preserve the experimental Kd value), kcat decreased to 0.074
s−1. This illustrates the dramatic inﬂuence that release of the tail
peptide has on the turnover rate.
Pre-steady-state experiments establish product release is
ordered, with the cyclic peptide departing the enzyme ﬁrst.
Analysis of the goodness of ﬁt of the data to the kinetic
sequence proposed here by Fitspace error analysis reveals
narrow conﬁdence intervals for the ﬁtted kinetic parameters
and well-deﬁned minima in the Fitspace contour plots (Figure
4). Furthermore, there is excellent agreement between
measured and calculated turnover numbers based on a rate
equation for the proposed kinetic sequence (Table 1 and eq
S1).
The single-turnover rate reported here (k2) is in fact a
macromolecular rate constant and consequently includes
several microscopic steps. Under single-turnover conditions,
we saturated the substrate with high concentrations of the
enzyme so that the rate measured encompasses steps that start
with the enzyme−substrate complex and end with the
enzyme−product complex. This includes chemistry (Scheme
S2)formation of the tetrahedral intermediate, formation of
the acyl−enzyme intermediate (as for other serine proteases),
and decomposition of the acyl−enzyme intermediate by
Figure 4. Fitspace contour error analysis of the global numerical ﬁtting
of the kinetic sequence proposed here. All experiments from Figures 3
and 4 were globally ﬁtted to the mechanism depicted. For the
simultaneous global ﬁtting of all experiments, k1 and k−1 and k5 and k−5
were linked by their experimentally determined Kd values
(Kd‑25mer‑S577A = 44 ± 10 nM, and Kd‑tail = 442 ± 60 nM). Chemistry
was considered irreversible (k−2 = 0). Additionally, k4 and k−4 were
ﬁxed at their best-ﬁt values. In these contour plots, k1, k2, k3, k−3, and k5
are shown as a function of each other, and deﬁned boundaries are
present for each kinetic parameter. χ2 at the boundary is 0.996.
Figure 5. Kinetic sequence determined here. Shown in the top panel is the generic nomenclature for the steps in the sequence. Shown in the middle
panel are steps with intermediates in the GmPOPB kinetic sequence and rate constants determined by global ﬁtting. Shown in the bottom panel is
the energy proﬁle for the entire reaction. Energy barriers were calculated according to eq 8. The purple curve represents initial rate conditions with
200 μM 25mer and 0.001 μM products. The green curve represents 50% conversion of the substrate into products (100 μM 25mer substrate, 100
μM cyclic peptide, and 100 μM peptide tail).
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nucleophilic attack by the 25mer N-terminal amine instead of
water, unique to macrocyclasesand any conformational
changes that accompany these chemical steps. Any one of
these or a combination could set a lower limit to the rate (k2)
observed here. Steady-state experiments performed with
porcine POP suggested that the steps following chemistry
could be rate-limiting, but rate constants were not measured for
individual steps.48
Close inspection of the energy barriers when the reaction is
occurring under initial velocity conditions as opposed to when
50% of the 25mer substrate has been consumed shows that
rebinding of the tail sequence contributes signiﬁcantly to the
turnover rate as the reaction progresses and the concentration
of the tail increases (Figure 5, bottom). In a simple equilibrium
kinetic analysis, the tail was shown to be an inhibitor of the
enzyme (Figure S10) supporting this model.
The need to understand an enzymatic process to improve it
has been emphasized for reactions that are important in
biocatalysis.49 Engineering of the heterocyclase enzyme LynD
involved in the formation of thiazolines in cyanobactin
biosynthesis reduced the size of the required peptide substrate
from >50 amino acids to only 12.50 No macrocyclase enzyme
has been engineered to improve or diversify function, although
their natural substrate promiscuity has been exploited.14−19,51
This is the ﬁrst kinetic characterization of a macrocyclase and a
necessary step toward designing a better catalyst for macro-
cyclization.
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